ghk-cu injection clinical trial humans Does Really Work? 40 Years of Research Reviewed The Human Tripeptide GHK-Cu in

Higher dosing: Some protocols use 500-750mcg twice daily for more severe injuries or faster results

The compound's high membrane permeability and metabolic stability make it suitable for both acute and chronic study designs, but researchers should be aware that its effects on NAD+ and methylation metabolism may require time to fully manifest

The formula is: Daily sublingual dose = (Weekly injectable dose x Injectable bioavailability) / (7 days x Sublingual bioavailability) Using 80% injectable and 30% sublingual bioavailability as the midpoint estimate: Daily sublingual = (Weekly injectable x 0.80) / (7 x 0.30) = Weekly injectable x 0.38 This means a 10 mg weekly injectable dose translates to approximately 3.8 mg daily sublingual

By entering this site you confirm you are of legal age